(NYSE: CBT) Cabot's forecast annual revenue growth rate of 4.24% is not forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 7.26%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 12.59%.
Cabot's revenue in 2026 is $3,634,000,000.On average, 8 Wall Street analysts forecast CBT's revenue for 2027 to be $197,695,125,803, with the lowest CBT revenue forecast at $186,904,245,340, and the highest CBT revenue forecast at $211,428,973,665. On average, 7 Wall Street analysts forecast CBT's revenue for 2028 to be $204,613,680,741, with the lowest CBT revenue forecast at $192,945,073,159, and the highest CBT revenue forecast at $220,361,137,876.
In 2029, CBT is forecast to generate $213,236,058,910 in revenue, with the lowest revenue forecast at $206,885,445,049 and the highest revenue forecast at $221,651,913,051.